Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.

Lütje S, Heskamp S, Franssen GM, Frielink C, Kip A, Hekman M, Fracasso G, Colombatti M, Herrmann K, Boerman OC, Gotthardt M, Rijpkema M.

Theranostics. 2019 May 4;9(10):2924-2938. doi: 10.7150/thno.35274. eCollection 2019.

2.

Can house sparrows recognize familiar or kin-related individuals by scent?

Fracasso G, Tuliozi B, Hoi H, Griggio M.

Curr Zool. 2019 Feb;65(1):53-59. doi: 10.1093/cz/zoy018. Epub 2018 Mar 7.

3.

In vitro gene expression and detergent-free reconstitution of active proteorhodopsin in lipid vesicles.

Fracasso G, Körner Y, Gonzales DTT, Dora Tang TY.

Exp Biol Med (Maywood). 2019 Mar;244(4):314-322. doi: 10.1177/1535370218820290. Epub 2019 Jan 10.

PMID:
30630374
4.

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes.

Fiore A, Ugel S, De Sanctis F, Sandri S, Fracasso G, Trovato R, Sartoris S, Solito S, Mandruzzato S, Vascotto F, Hippen KL, Mondanelli G, Grohmann U, Piro G, Carbone C, Melisi D, Lawlor RT, Scarpa A, Lamolinara A, Iezzi M, Fassan M, Bicciato S, Blazar BR, Sahin U, Murray PJ, Bronte V.

Nat Commun. 2018 Dec 5;9(1):5193. doi: 10.1038/s41467-018-07654-4.

5.

Acute Sarcomeric M-Line Disease Associated With ATP Synthase Subunit α Autoantibodies in Ankylosing Spondylitis.

Guglielmi V, Vattemi G, Cecconi D, Fracasso G, Marini M, Tomelleri G.

J Neuropathol Exp Neurol. 2018 Nov 1;77(11):987-992. doi: 10.1093/jnen/nly079.

PMID:
30215745
6.

House sparrows' (Passer domesticus) behaviour in a novel environment is modulated by social context and familiarity in a sex-specific manner.

Tuliozi B, Fracasso G, Hoi H, Griggio M.

Front Zool. 2018 Apr 20;15:16. doi: 10.1186/s12983-018-0267-8. eCollection 2018.

7.

Nanoaggregates of iron poly-oxo-clusters obtained by laser ablation in aqueous solution of phosphonates.

Fracasso G, Ghigna P, Nodari L, Agnoli S, Badocco D, Pastore P, Nicolato E, Marzola P, Mihajlović D, Markovic M, Čolić M, Amendola V.

J Colloid Interface Sci. 2018 Jul 15;522:208-216. doi: 10.1016/j.jcis.2018.03.065. Epub 2018 Mar 20.

PMID:
29604440
8.

The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity.

Falvo E, Malagrinò F, Arcovito A, Fazi F, Colotti G, Tremante E, Di Micco P, Braca A, Opri R, Giuffrè A, Fracasso G, Ceci P.

J Control Release. 2018 Apr 10;275:177-185. doi: 10.1016/j.jconrel.2018.02.025. Epub 2018 Feb 20.

PMID:
29474961
9.

A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia.

Litti L, Rivato N, Fracasso G, Bontempi P, Nicolato E, Marzola P, Venzo A, Colombatti M, Gobbo M, Meneghetti M.

Nanoscale. 2018 Jan 18;10(3):1272-1278. doi: 10.1039/c7nr07398d.

PMID:
29292448
10.

Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells.

Bertorelle F, Pinto M, Zappon R, Pilot R, Litti L, Fiameni S, Conti G, Gobbo M, Toffoli G, Colombatti M, Fracasso G, Meneghetti M.

Nanoscale. 2018 Jan 18;10(3):976-984. doi: 10.1039/c7nr07844g.

PMID:
29264608
11.

Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.

Lütje S, Gerrits D, Molkenboer-Kuenen JD, Herrmann K, Fracasso G, Colombatti M, Boerman OC, Heskamp S.

J Nucl Med. 2018 Mar;59(3):494-501. doi: 10.2967/jnumed.117.196279. Epub 2017 Nov 16.

12.

Gene-Mediated Chemical Communication in Synthetic Protocell Communities.

Tang TD, Cecchi D, Fracasso G, Accardi D, Coutable-Pennarun A, Mansy SS, Perriman AW, Anderson JLR, Mann S.

ACS Synth Biol. 2018 Feb 16;7(2):339-346. doi: 10.1021/acssynbio.7b00306. Epub 2017 Nov 8.

PMID:
29091420
13.

Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.

Damiani V, Falvo E, Fracasso G, Federici L, Pitea M, De Laurenzi V, Sala G, Ceci P.

Int J Mol Sci. 2017 Jul 18;18(7). pii: E1555. doi: 10.3390/ijms18071555.

14.

Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells.

Ringhieri P, Mannucci S, Conti G, Nicolato E, Fracasso G, Marzola P, Morelli G, Accardo A.

Int J Nanomedicine. 2017 Jan 13;12:501-514. doi: 10.2147/IJN.S113607. eCollection 2017.

15.

Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.

Frigerio B, Franssen G, Luison E, Satta A, Seregni E, Colombatti M, Fracasso G, Valdagni R, Mezzanzanica D, Boerman O, Canevari S, Figini M.

Oncotarget. 2017 Feb 14;8(7):10919-10930. doi: 10.18632/oncotarget.14229.

16.

Olfactory Assessment of Competitors to the Nest Site: An Experiment on a Passerine Species.

Griggio M, Fracasso G, Mahr K, Hoi H.

PLoS One. 2016 Dec 9;11(12):e0167905. doi: 10.1371/journal.pone.0167905. eCollection 2016.

17.

Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".

Perico ME, Grasso S, Brunelli M, Martignoni G, Munari E, Moiso E, Fracasso G, Cestari T, Naim HY, Bronte V, Colombatti M, Ramarli D.

Oncotarget. 2016 Nov 8;7(45):74189-74202. doi: 10.18632/oncotarget.12404.

18.

Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness.

Fracasso G, Falvo E, Colotti G, Fazi F, Ingegnere T, Amalfitano A, Doglietto GB, Alfieri S, Boffi A, Morea V, Conti G, Tremante E, Giacomini P, Arcovito A, Ceci P.

J Control Release. 2016 Oct 10;239:10-8. doi: 10.1016/j.jconrel.2016.08.010. Epub 2016 Aug 12.

PMID:
27524282
19.

Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.

Sandri S, Bobisse S, Moxley K, Lamolinara A, De Sanctis F, Boschi F, Sbarbati A, Fracasso G, Ferrarini G, Hendriks RW, Cavallini C, Scupoli MT, Sartoris S, Iezzi M, Nishimura MI, Bronte V, Ugel S.

Cancer Res. 2016 May 1;76(9):2540-51. doi: 10.1158/0008-5472.CAN-15-2318.

20.

In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.

Mazzocco C, Fracasso G, Germain-Genevois C, Dugot-Senant N, Figini M, Colombatti M, Grenier N, Couillaud F.

Sci Rep. 2016 Mar 21;6:23314. doi: 10.1038/srep23314.

21.

Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements.

Falvo E, Tremante E, Arcovito A, Papi M, Elad N, Boffi A, Morea V, Conti G, Toffoli G, Fracasso G, Giacomini P, Ceci P.

Biomacromolecules. 2016 Feb 8;17(2):514-22. doi: 10.1021/acs.biomac.5b01446. Epub 2015 Dec 30.

PMID:
26686226
22.

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen.

Frigerio B, Benigni F, Luison E, Seregni E, Pascali C, Fracasso G, Morlino S, Valdagni R, Mezzanzanica D, Canevari S, Figini M.

Immunol Lett. 2015 Nov;168(1):105-10. doi: 10.1016/j.imlet.2015.09.012. Epub 2015 Sep 25.

PMID:
26404855
23.

An electrochemiluminescence-supramolecular approach to sarcosine detection for early diagnosis of prostate cancer.

Valenti G, Rampazzo E, Biavardi E, Villani E, Fracasso G, Marcaccio M, Bertani F, Ramarli D, Dalcanale E, Paolucci F, Prodi L.

Faraday Discuss. 2015;185:299-309. doi: 10.1039/c5fd00096c.

PMID:
26394608
24.

Laser generated gold nanocorals with broadband plasmon absorption for photothermal applications.

Poletti A, Fracasso G, Conti G, Pilot R, Amendola V.

Nanoscale. 2015 Aug 28;7(32):13702-14. doi: 10.1039/c5nr03442f. Epub 2015 Jul 29.

PMID:
26219425
25.

Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection.

Tardivo M, Toffoli V, Fracasso G, Borin D, Dal Zilio S, Colusso A, Carrato S, Scoles G, Meneghetti M, Colombatti M, Lazzarino M.

Biosens Bioelectron. 2015 Oct 15;72:393-9. doi: 10.1016/j.bios.2015.05.026. Epub 2015 May 18.

PMID:
26025134
26.

PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models.

Zuccolotto G, Fracasso G, Merlo A, Montagner IM, Rondina M, Bobisse S, Figini M, Cingarlini S, Colombatti M, Zanovello P, Rosato A.

PLoS One. 2014 Oct 3;9(10):e109427. doi: 10.1371/journal.pone.0109427. eCollection 2014.

27.

Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA).

Tykvart J, Navrátil V, Sedlák F, Corey E, Colombatti M, Fracasso G, Koukolík F, Bařinka C, Sácha P, Konvalinka J.

Prostate. 2014 Dec;74(16):1674-90. doi: 10.1002/pros.22887. Epub 2014 Sep 27.

PMID:
25262926
28.

Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.

Lütje S, van Rij CM, Franssen GM, Fracasso G, Helfrich W, Eek A, Oyen WJ, Colombatti M, Boerman OC.

Contrast Media Mol Imaging. 2015 Jan-Feb;10(1):28-36. doi: 10.1002/cmmi.1596. Epub 2014 Apr 25.

PMID:
24764162
29.

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.

Lütje S, Rijpkema M, Franssen GM, Fracasso G, Helfrich W, Eek A, Oyen WJ, Colombatti M, Boerman OC.

J Nucl Med. 2014 Jun;55(6):995-1001. doi: 10.2967/jnumed.114.138180. Epub 2014 Apr 3.

30.

Magneto-plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging.

Amendola V, Scaramuzza S, Litti L, Meneghetti M, Zuccolotto G, Rosato A, Nicolato E, Marzola P, Fracasso G, Anselmi C, Pinto M, Colombatti M.

Small. 2014 Jun 25;10(12):2476-86. doi: 10.1002/smll.201303372. Epub 2014 Mar 11. Erratum in: Small. 2014 Oct 15;10(19):3823.

PMID:
24619736
31.

Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen.

Schmidt S, Gericke B, Fracasso G, Ramarli D, Colombatti M, Naim HY.

PLoS One. 2013 Jun 19;8(6):e66193. doi: 10.1371/journal.pone.0066193. Print 2013.

32.

Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems.

Selvestrel F, Moret F, Segat D, Woodhams JH, Fracasso G, Echevarria IM, Baù L, Rastrelli F, Compagnin C, Reddi E, Fedeli C, Papini E, Tavano R, MacKenzie A, Bovis M, Yaghini E, MacRobert AJ, Zanini S, Boscaini A, Colombatti M, Mancin F.

Nanoscale. 2013 Jul 7;5(13):6106-16. doi: 10.1039/c3nr00402c. Epub 2013 May 31.

PMID:
23728482
33.

A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer.

Frigerio B, Fracasso G, Luison E, Cingarlini S, Mortarino M, Coliva A, Seregni E, Bombardieri E, Zuccolotto G, Rosato A, Colombatti M, Canevari S, Figini M.

Eur J Cancer. 2013 Jun;49(9):2223-32. doi: 10.1016/j.ejca.2013.01.024. Epub 2013 Feb 20.

PMID:
23433847
34.

Cloning and characterization of canine prostate-specific membrane antigen.

Schmidt S, Fracasso G, Colombatti M, Naim HY.

Prostate. 2013 May;73(6):642-50. doi: 10.1002/pros.22605. Epub 2013 Jan 28.

PMID:
23359458
35.

Plasmonic nanostructures for SERRS multiplexed identification of tumor-associated antigens.

Meneghetti M, Scarsi A, Litti L, Marcolongo G, Amendola V, Gobbo M, Di Chio M, Boscaini A, Fracasso G, Colombatti M.

Small. 2012 Dec 21;8(24):3733-8. doi: 10.1002/smll.201201196. Epub 2012 Aug 24. No abstract available.

PMID:
22927257
36.

Usefulness of transcranial color Doppler ultrasonography in aortic arch surgery.

Catena E, Tasca G, Fracasso G, Toscano A, Bonacina M, Narang T, Galanti A, Triggiani M, Lorenzi G, Gamba A.

J Cardiovasc Med (Hagerstown). 2013 Aug;14(8):597-602. doi: 10.2459/JCM.0b013e328356a485.

PMID:
22801076
37.

Intravitreal bevacizumab for posttraumatic choroidal neovascularization in a child.

Piermarocchi S, Benetti E, Fracasso G.

J AAPOS. 2011 Jun;15(3):314-6. doi: 10.1016/j.jaapos.2011.02.008. Epub 2011 Jun 12.

PMID:
21665504
38.

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma.

Jachimowicz RD, Fracasso G, Yazaki PJ, Power BE, Borchmann P, Engert A, Hansen HP, Reiners KS, Marie M, von Strandmann EP, Rothe A.

Mol Cancer Ther. 2011 Jun;10(6):1036-45. doi: 10.1158/1535-7163.MCT-10-1093. Epub 2011 Apr 27.

39.

Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.

Papa M, Gaspardone A, Fragasso G, Ajello S, Gioffrè G, Iamele M, Iani C, Margonato A.

Am J Cardiol. 2009 Aug 1;104(3):434-9. doi: 10.1016/j.amjcard.2009.03.061. Epub 2009 Jun 6. Erratum in: Am J Cardiol. 2009 Nov 1;104(9):1315. Fracasso, Gabriele [corrected to Fragasso, Gabriele].

PMID:
19616680
40.

The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways.

Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, Cingarlini S, Poffe O, Naim HY, Heine M, Tridente G, Mainiero F, Ramarli D.

PLoS One. 2009;4(2):e4608. doi: 10.1371/journal.pone.0004608. Epub 2009 Feb 26. Erratum in: PLoS ONE. 2009;4(3). doi: 10.1371/annotation/f290f38a-4f71-43ad-b988-9f8d5a7329fe.

41.

Thoracic epidural anaesthesia in valvular cardiac surgery.

Crescenzi G, Covello RD, Landoni G, De Luca M, Fracasso G, Melone M, Serini SM, Bignami E, Rosica C, Zangrillo A.

Eur J Anaesthesiol. 2008 Apr;25(4):339-40. doi: 10.1017/S0265021507002840. No abstract available.

PMID:
18334038
42.

Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes.

Castelletti D, Alfalah M, Heine M, Hein Z, Schmitte R, Fracasso G, Colombatti M, Naim HY.

Biochem J. 2008 Jan 1;409(1):149-57.

PMID:
17935484
43.

N-terminal deletion affects catalytic activity of saporin toxin.

Bonini F, Traini R, Comper F, Fracasso G, Tomazzolli R, Dalla Serra M, Colombatti M.

J Cell Biochem. 2006 Aug 1;98(5):1130-9.

PMID:
16775836
44.

Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells.

Colombara M, Antonini V, Riviera AP, Mainiero F, Strippoli R, Merola M, Fracasso G, Poffe O, Brutti N, Tridente G, Colombatti M, Ramarli D.

J Immunol. 2005 Nov 15;175(10):7021-8.

45.

Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing.

Castelletti D, Fracasso G, Alfalah M, Cingarlini S, Colombatti M, Naim HY.

J Biol Chem. 2006 Feb 10;281(6):3505-12. Epub 2005 Oct 12.

46.

Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery.

Zangrillo A, Landoni G, Sparicio D, Benussi S, Aletti G, Pappalardo F, Fracasso G, Fano G, Crescenzi G.

J Cardiothorac Vasc Anesth. 2004 Dec;18(6):704-8.

PMID:
15650977
47.

Gangliosides act as onconeural antigens in paraneoplastic neuropathies.

De Toni L, Marconi S, Nardelli E, Alberti D, Borsellino G, Fracasso G, Bach S, Bertolasi L, Santo A, Bassi A, Tramonti D, Battistini L, Bonetti B.

J Neuroimmunol. 2004 Nov;156(1-2):178-87. Erratum in: J Neuroimmunol. 2005 May;162(1-2):194-6.

PMID:
15465609
48.

Immunotoxins and other conjugates: preparation and general characteristics.

Fracasso G, Bellisola G, Castelletti D, Tridente G, Colombatti M.

Mini Rev Med Chem. 2004 Jun;4(5):545-62. Review.

PMID:
15180510
49.

A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin.

Castelletti D, Fracasso G, Righetti S, Tridente G, Schnell R, Engert A, Colombatti M.

Clin Exp Immunol. 2004 May;136(2):365-72.

50.

Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.

Bellisola G, Fracasso G, Ippoliti R, Menestrina G, Rosén A, Soldà S, Udali S, Tomazzolli R, Tridente G, Colombatti M.

Biochem Pharmacol. 2004 May 1;67(9):1721-31.

PMID:
15081871

Supplemental Content

Loading ...
Support Center